US Biosimilars Market: Is the "Rebate Wall" Still the...

added blog Health

2026-02-02 11:22:38 -

The global pharmaceutical landscape is entering a transformative era as the patents for several blockbuster biologics expire, paving the way for more affordable alternatives. As of 2026, the Biosimilars Market is reaching new heights, driven by an urgent need to contain healthcare costs as chronic disease rates climb. These follow-on biologics, which are highly similar to their reference...

0 Comments 0 Shares 161 Views 0 Reviews